apr 017  (Alomone Labs)

Journal: Current Issues in Molecular Biology

Article Title: Precision Intervention of Isorhamnetin Total Flavonoids in Ischemic Heart Failure: Mechanistic Exploration Based on Signature Gene Targets

doi: 10.3390/cimb48040406

Figure Lengend Snippet: Differential expression of signature genes and diagnostic performance analysis. ( A – D ) Box plots of signature gene expression levels in control (Con) versus treated (Treat) groups, demonstrating expression differences and statistical significance for C10TNF9, CCR1, CD163, and P2RY13; ( E – H ) ROC curve analysis of signature genes, demonstrating diagnostic performance (AUC values and 95% confidence intervals) for each gene, reflecting their ability to distinguish between the two sample groups.

Article Snippet: The primers for the CTRP9, P2Y13, and CCR1 genes used in this experiment were synthesized by Shanghai Sangon Biotech Co., Ltd., with their sequences listed in .

Techniques: Quantitative Proteomics, Diagnostic Assay, Gene Expression, Control, Expressing

Journal: Current Issues in Molecular Biology

Article Title: Precision Intervention of Isorhamnetin Total Flavonoids in Ischemic Heart Failure: Mechanistic Exploration Based on Signature Gene Targets

doi: 10.3390/cimb48040406

Figure Lengend Snippet: mRNA expression levels of target genes in different treatment groups. ( A ) C1QTNF9 mRNA levels: Expression was significantly elevated in the MIRI group, while MIRI + TFDM and MIRI + Y treatments downregulated its expression. ( B ) P2RY13 mRNA levels: The trend was consistent with C1QTNF9; the MIRI group showed upregulation, while the intervention groups showed reduced expression levels. ( C ) CCR1 mRNA levels: The MIRI group showed reduced expression, while the MIRI + TFDM and MIRI + Y treatments restored expression. Note: # and ## indicate significant differences from the control group ( # p < 0.05, ## p < 0.01); * and ** indicate significant differences from the MIRI group (* p < 0.05, ** p < 0.01), reflecting statistical significance in expression levels between groups.

Article Snippet: The primers for the CTRP9, P2Y13, and CCR1 genes used in this experiment were synthesized by Shanghai Sangon Biotech Co., Ltd., with their sequences listed in .

Techniques: Expressing, Control

Journal: Current Issues in Molecular Biology

Article Title: Precision Intervention of Isorhamnetin Total Flavonoids in Ischemic Heart Failure: Mechanistic Exploration Based on Signature Gene Targets

doi: 10.3390/cimb48040406

Figure Lengend Snippet: Expression levels of the target proteins in different treatment groups. ( A ) Western blot results: protein bands for CTRP9, P2Y13, CCR1, and the housekeeping gene GAPDH (labeled with corresponding molecular weights). ( B ) Relative expression levels of CTRP9 protein, which were significantly upregulated in the MIRI group; MIRI + TFDM and MIRI + Y treatments reduced its expression. ( C ) Relative expression levels of P2Y13 protein: The trend was consistent with CTRP9: elevated in MIRI group and downregulated in the intervention groups. ( D ) Relative expression of CCR1 protein, which was decreased in the MIRI group and restored in MIRI + TFDM and MIRI + Y treatments (Note: ## indicates a statistically significant difference from the control group; ** indicates an extremely statistically significant difference from the control group; * indicates a statistically significant difference from the MIRI group, reflecting the statistical significance of protein levels between groups).

Article Snippet: The primers for the CTRP9, P2Y13, and CCR1 genes used in this experiment were synthesized by Shanghai Sangon Biotech Co., Ltd., with their sequences listed in .

Techniques: Expressing, Western Blot, Labeling, Control

Journal: Cellular and Molecular Life Sciences: CMLS

Article Title: Identification of epileptic hippocampal sclerosis related genes through bulk and single-nucleus RNA sequencing datasets

doi: 10.1007/s00018-025-05959-4

Figure Lengend Snippet: Gene expression validation in KA-induced epilepsy model. A Diagram illustrating the KA-induced epilepsy model, including KA injection, EEG recording, and brain tissue collection for qPCR and Western blot analyses at specified time points. B Quantification of TMEM156, PSD4, CFAP47, and P2RY13 mRNA expression level relative to Gapdh by qPCR in hippocampal tissues from KA-treated and control mice ( n = 3 per group). C EEG recordings of control and KA-treated mice at 30 days post-injection, with seizure-like discharges observed in the KA group. (CC: contralateral cortex; CH: contralateral hippocampus) D - E Western blot analysis and quantification of CFAP47 and P2Y13 protein expression in hippocampal tissues from KA-treated and control mice ( n = 6 per group). Statistical significance is indicated as p < 0.05 (*), p < 0.01 (), p < 0.001 (*), and p < 0.0001 (****)

Article Snippet: Membranes were blocked with 5% skim milk and incubated with primary antibodies, including CFAP47 polyclonal antibody (20837-1-AP, Proteintech, 1:1000), P2Y13 antibody (sc-517219, Santa Cruz Biotechnology, 1:1000), and recombinant anti-GAPDH antibody (GB15004-100, Servicebio, 1:500).

Techniques: Gene Expression, Biomarker Discovery, Injection, Western Blot, Expressing, Control

Journal: The Journal of Headache and Pain

Article Title: The P2Y13 receptor-mediated microglial morphological transformation through the p38MAPK signaling pathway contributes to central sensitization in a murine model of chronic migraine

doi: 10.1186/s10194-025-02251-5

Figure Lengend Snippet: P2Y13R is present in microglia and shows significant upregulation after repeated NTG injections. a , b Western blotting analysis of P2Y13R on different days after NTG injection ( n = 5 mice / group). c The yellow dotted box delineates the area of TNC. d Dual immunofluorescence staining of P2Y13R with Iba1, GFAP, NeuN ( n = 4 mice / group). Scale bar: 20 μm. The values represent the mean ± SEM; statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc tests; *** p < 0.001 vs. the sham group

Article Snippet: P2Y13R , Alomone, Israel , APR-017 , Rabbit , 1:50.

Techniques: Western Blot, Injection, Immunofluorescence, Staining

Journal: The Journal of Headache and Pain

Article Title: The P2Y13 receptor-mediated microglial morphological transformation through the p38MAPK signaling pathway contributes to central sensitization in a murine model of chronic migraine

doi: 10.1186/s10194-025-02251-5

Figure Lengend Snippet: P2Y13R Inhibition alleviates mechanical and thermal hyperalgesia caused by NTG. Measurement of hind paw ( a , b ), periocular ( c , d ) mechanical threshold, and thermal withdrawal latency ( e , f ). n = 10, the values represent the mean ± SEM; statistical analysis was performed using two-way ANOVA followed by Tukey’s post hoc tests. *** p < 0.001 vs. the VEH group; # p < 0.05, ## p < 0.01, ### p < 0.001 vs. the NTG group

Article Snippet: P2Y13R , Alomone, Israel , APR-017 , Rabbit , 1:50.

Techniques: Inhibition

Journal: The Journal of Headache and Pain

Article Title: The P2Y13 receptor-mediated microglial morphological transformation through the p38MAPK signaling pathway contributes to central sensitization in a murine model of chronic migraine

doi: 10.1186/s10194-025-02251-5

Figure Lengend Snippet: P2Y13R inhibition led to a notable reduction in the levels of c-fos and CGRP expression. a Schematic diagram of microinjection in the TNC region in mice. b , c Western blotting analysis of P2Y13R ( n = 5 mice per group). d - f Western blotting analysis of c-fos and CGRP ( n = 5 mice / group). g , h Immunofluorescence analysis of CGRP ( n = 4 mice / group). i , j Immunofluorescence analysis of c-fos ( n = 4 mice / group). The values represent the mean ± SEM; statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc tests; *** p < 0.001 vs. the VEH group; ### p < 0.001 vs. the NTG group

Article Snippet: P2Y13R , Alomone, Israel , APR-017 , Rabbit , 1:50.

Techniques: Inhibition, Expressing, Microinjection, Western Blot, Immunofluorescence

Journal: The Journal of Headache and Pain

Article Title: The P2Y13 receptor-mediated microglial morphological transformation through the p38MAPK signaling pathway contributes to central sensitization in a murine model of chronic migraine

doi: 10.1186/s10194-025-02251-5

Figure Lengend Snippet: P2Y13R affects the morphological alterations of activated microglia and the production of inflammatory factors. a Immunofluorescence staining of Iba1 in different groups. b Enlarged image of microglia in the white dotted box in a. c - g Quantification of the number of Iba1 + microglia, immunoreactivity of Iba1, total length of initial processes, average length of initial processes and soma size in microglia ( n = 4 mice / group). h-k . Western blotting analysis of IL-1β, IL-6, TNF-α ( n = 5 mice / group). Values are presented as the mean ± SEM; statistical analysis was performed using one-way ANOVA followed by Tukey’s post hoc tests; *** p < 0.001 vs. the VEH group; ### p < 0.001 vs. the NTG group

Article Snippet: P2Y13R , Alomone, Israel , APR-017 , Rabbit , 1:50.

Techniques: Immunofluorescence, Staining, Western Blot

Journal: bioRxiv

Article Title: Purinergic Receptor P2Y 13 Controls Activation and Mode of Division in Subependymal Adult Neural Stem Cells

doi: 10.1101/2024.11.29.626065

Figure Lengend Snippet: The P2Y 13 receptor is expressed by qNSCs in the adult SEZ. A. The expression of the different metabotropic P2Y receptors in the adult SEZ was analyzed by quantitative RT-PCR (n=6). B. P2Y 13 receptor expression in the ventral and dorsal wall of the adult SEZ analyzed by quantitative RT-PCR (n=6). C . Comparison of the P2Y 13 receptor protein in the ventral and dorsal wall of the SEZ (n=3). D-F . P2Y 13 receptor expression in the ventral wall of the SEZ. Note how the P2Y 13 receptor (red) co-localizes with GFAP positive (white) astroglia (yellow arrowheads) but not with Ascl1 positive TAPs or cells expressing βIII-tubulin (green, scale bar 30 µm except for Ascl1 10 µm). G . Co-localization of the P2Y 13 receptor (red) in NSCs with SOX2 (white) and GFAP (green) in the adult SEZ (scale bar 30 µm). H. SEZ-derived cell populations expressing the P2Y 13 receptor in a FACs analysis using a P2Y 13 -GFP conjugated antibody. Note how the expression is mainly associated with the qNSC fraction (n=3). All graphs show the mean ±SEM: *p<0.05, **p<0.01, and ***p<0.001 (T-test).

Article Snippet: Both the cells and tissue sections were then incubated overnight at 4 °C with the primary antibodies: rabbit anti-P2Y 13 (1:100, Alomone Labs Cat# APR-009), rabbit anti-P2Y 1 (1:100, Alomone Labs Cat# APR-017), rabbit anti-SOX2 (1:100, ABclonal Cat# A0561), mouse anti-GFAP (1:200, Sigma-Aldrich Cat# G3893), mouse anti-βIII-Tubulin (1:800, Sigma-Aldrich Cat# T8660), guinea pig anti-(Doublecortin)DCX (1:400, Millipore Cat# AB2253), mouse anti-ASCL1 (1:100, BD Biosciences Cat# 556604), rabbit anti-KI67 (1:100, Fisher Scientific Cat# RM-9106-S), and chicken anti-GFP (1:400, AvesLab Cat# GFP-1020).

Techniques: Expressing, Quantitative RT-PCR, Comparison, Derivative Assay

Journal: bioRxiv

Article Title: Purinergic Receptor P2Y 13 Controls Activation and Mode of Division in Subependymal Adult Neural Stem Cells

doi: 10.1101/2024.11.29.626065

Figure Lengend Snippet: Expression of the P2Y 13 receptor in the neurogenic lineage of the SEZ-derived cell cultures after 6 DIV: GFAP (magenta), Ascl1 (green, middle panel), βIII-tubulin (green, lower panel), P2Y 13 (red). Note how P2Y 13 receptor expression only co-localizes with GFAP in cells. Scale bar 30 µm.

Article Snippet: Both the cells and tissue sections were then incubated overnight at 4 °C with the primary antibodies: rabbit anti-P2Y 13 (1:100, Alomone Labs Cat# APR-009), rabbit anti-P2Y 1 (1:100, Alomone Labs Cat# APR-017), rabbit anti-SOX2 (1:100, ABclonal Cat# A0561), mouse anti-GFAP (1:200, Sigma-Aldrich Cat# G3893), mouse anti-βIII-Tubulin (1:800, Sigma-Aldrich Cat# T8660), guinea pig anti-(Doublecortin)DCX (1:400, Millipore Cat# AB2253), mouse anti-ASCL1 (1:100, BD Biosciences Cat# 556604), rabbit anti-KI67 (1:100, Fisher Scientific Cat# RM-9106-S), and chicken anti-GFP (1:400, AvesLab Cat# GFP-1020).

Techniques: Expressing, Derivative Assay

Journal: bioRxiv

Article Title: Purinergic Receptor P2Y 13 Controls Activation and Mode of Division in Subependymal Adult Neural Stem Cells

doi: 10.1101/2024.11.29.626065

Figure Lengend Snippet: The P2Y 13 receptor is active in SEZ-derived NSCs in culture. NSCs in culture and loaded with the calcium dye Fura-2 were stimulated with 2MeSADP and after a washout period, they were re-exposed to 2MeSADP in the presence of either the P2Y1 receptor antagonist MRS2179 A or the P2Y 13 receptor antagonist MRS2179 B . All compounds were tested at a concentration of 10 μM and representative traces of the F340/F380 fluorescence ratios recorded from single cells are shown. C . Immunocytochemistry identifying GFAP (green) and SOX2 (red) double positive NSCs that respond to the selective agonist of the P2Y 13 receptor, 2MeSADP (yellow arrowheads). Conversely, the intracellular calcium levels of GFAP positive parenchymal astrocytes (white arrow) does not change. D . Effects of 2MeSADP on voltage-gated currents in SEZ-derived NSCs in culture. Outward currents evoked by a depolarising pulse (+10 mV, 100 ms from a Vh of −80 mV) were increased in the presence of 2MeSADP (10 µM, 2 min). Subsequent exposure to MRS221 (10 µM, 2 min) partially reversed the potentiating effect of 2MeSADP (upper panel). At variance, exposure to MRS2179 (10 µM, 2 min) of 2MeSADP with MRS2179 (10 µM, 2 min) did not have any effect on outward current increase elicited by 2MeSADP (10 µM, 2 min) (lower panel). E . Scatter plot of outward current charges from the experiments shown in ( D ), in the presence or absence of 2MeSADP (10 µM, 2 min: left panel), and following co-incubation (right panels) with MRS2211 (upper right) or MRS2179 (lower right). The values are the means ± SEM of the number of cells indicated between parentheses; the statistical significance was assessed using the student’s T-test for paired samples: *p < 0.05; **p < 0.01.

Article Snippet: Both the cells and tissue sections were then incubated overnight at 4 °C with the primary antibodies: rabbit anti-P2Y 13 (1:100, Alomone Labs Cat# APR-009), rabbit anti-P2Y 1 (1:100, Alomone Labs Cat# APR-017), rabbit anti-SOX2 (1:100, ABclonal Cat# A0561), mouse anti-GFAP (1:200, Sigma-Aldrich Cat# G3893), mouse anti-βIII-Tubulin (1:800, Sigma-Aldrich Cat# T8660), guinea pig anti-(Doublecortin)DCX (1:400, Millipore Cat# AB2253), mouse anti-ASCL1 (1:100, BD Biosciences Cat# 556604), rabbit anti-KI67 (1:100, Fisher Scientific Cat# RM-9106-S), and chicken anti-GFP (1:400, AvesLab Cat# GFP-1020).

Techniques: Derivative Assay, Concentration Assay, Fluorescence, Immunocytochemistry, Incubation

Journal: bioRxiv

Article Title: Purinergic Receptor P2Y 13 Controls Activation and Mode of Division in Subependymal Adult Neural Stem Cells

doi: 10.1101/2024.11.29.626065

Figure Lengend Snippet: P2Y 13 silencing increases the number of NSCs remaining in the SEZ without promoting proliferation. A. The effect of local P2Y 13 receptor silencing on the NSC population, achieved using the CRISPR/Cas9 sgP2Y 13 lentiviral vectors: Cas9 (Green), SOX2 (Magenta) and GFAP (White), the cell nuclei are stained with DAPI. The lower panels show a higher magnification of the selected areas (scale bar 50 µm). B. Quantification of the Cas9 + /GFAP + /SOX2 + cells remaining in the adult SEZ (n=4). C Effect of the local silencing of the P2Y 13 receptor using the CRISPR/Cas9 sgP2Y 13 lentiviral vectors on the proliferation within the SEZ: Cas9 (Green), Ki67 (Magenta) and GFAP (White), the cell nuclei are stained with DAPI. The lower panels show a higher magnification of the selected areas (scale bar 50 µm). D . Quantification of the Cas9 + /Ki67 + cells SEZ (n=4). E . Effect of local silencing of the P2Y 13 receptor using the CRISPR/Cas9 sgP2Y 13 lentiviral vectors on the neuroblast population: Cas9 (Green), DCX (White) and the cell nuclei are stained with DAPI. The lower panels show the higher magnification of the selected areas (scale bar 50 µm). F. Quantification of the Cas9 + /DCX + cells (n=4). All graphs show mean ±SEM: ***p<0.001 (T-test).

Article Snippet: Both the cells and tissue sections were then incubated overnight at 4 °C with the primary antibodies: rabbit anti-P2Y 13 (1:100, Alomone Labs Cat# APR-009), rabbit anti-P2Y 1 (1:100, Alomone Labs Cat# APR-017), rabbit anti-SOX2 (1:100, ABclonal Cat# A0561), mouse anti-GFAP (1:200, Sigma-Aldrich Cat# G3893), mouse anti-βIII-Tubulin (1:800, Sigma-Aldrich Cat# T8660), guinea pig anti-(Doublecortin)DCX (1:400, Millipore Cat# AB2253), mouse anti-ASCL1 (1:100, BD Biosciences Cat# 556604), rabbit anti-KI67 (1:100, Fisher Scientific Cat# RM-9106-S), and chicken anti-GFP (1:400, AvesLab Cat# GFP-1020).

Techniques: CRISPR, Staining

Journal: bioRxiv

Article Title: Purinergic Receptor P2Y 13 Controls Activation and Mode of Division in Subependymal Adult Neural Stem Cells

doi: 10.1101/2024.11.29.626065

Figure Lengend Snippet: Scheme of the strategy to generate lentiviral vectors for the local overexpression of the P2Y 13 receptor. B . Experimental design of lentiviral injection for local overexpression or silencing of the P2Y 13 receptor. C . Positive control of the local overexpression of P2Y 13 receptor. Lentiviral injection in the adult SEZ demonstrated that all LV-GFP-P2Y 13 transduced cells (Green) co-localized with P2Y 13 expression (red).

Article Snippet: Both the cells and tissue sections were then incubated overnight at 4 °C with the primary antibodies: rabbit anti-P2Y 13 (1:100, Alomone Labs Cat# APR-009), rabbit anti-P2Y 1 (1:100, Alomone Labs Cat# APR-017), rabbit anti-SOX2 (1:100, ABclonal Cat# A0561), mouse anti-GFAP (1:200, Sigma-Aldrich Cat# G3893), mouse anti-βIII-Tubulin (1:800, Sigma-Aldrich Cat# T8660), guinea pig anti-(Doublecortin)DCX (1:400, Millipore Cat# AB2253), mouse anti-ASCL1 (1:100, BD Biosciences Cat# 556604), rabbit anti-KI67 (1:100, Fisher Scientific Cat# RM-9106-S), and chicken anti-GFP (1:400, AvesLab Cat# GFP-1020).

Techniques: Over Expression, Injection, Positive Control, Expressing

Journal: bioRxiv

Article Title: Purinergic Receptor P2Y 13 Controls Activation and Mode of Division in Subependymal Adult Neural Stem Cells

doi: 10.1101/2024.11.29.626065

Figure Lengend Snippet: Local overexpression of P2Y 13 receptors augments the proportion of cells in the RMS and decreases the number of NSCs remaining in the ventral wall of the SEZ. A. Effect of P2Y 13 on SEZ dynamics, with local overexpression promoting more cells entering the RMS and less cells remaining in the SEZ (Scale bar 50 µm). B Quantification of GFP positive cells in the ventral wall of the SEZ and RMS following LV-GFP injection (n=4). C Quantification of GFP + cells in the ventral wall of the SEZ and RMS following LV-P2Y 13 -GFP injections (n=4, scale bar 50 µm). D-E. Effect of local overexpression on the remaining GFAP + (white)/SOX2 + (red)/GFP + (Green) cells in the SEZ after LV-GFP or LV-P2Y 13 -GFP injections (n=4, scale bar 50 µM). F. Quantification of GFAP + /SOX2 + /GFP + cells in the ventral wall of the SEZ following LV-GFP or LV-P2Y 13 -GFP injections (n=4). All graphs show the mean ±SEM: *p<0.05 (T-test).

Article Snippet: Both the cells and tissue sections were then incubated overnight at 4 °C with the primary antibodies: rabbit anti-P2Y 13 (1:100, Alomone Labs Cat# APR-009), rabbit anti-P2Y 1 (1:100, Alomone Labs Cat# APR-017), rabbit anti-SOX2 (1:100, ABclonal Cat# A0561), mouse anti-GFAP (1:200, Sigma-Aldrich Cat# G3893), mouse anti-βIII-Tubulin (1:800, Sigma-Aldrich Cat# T8660), guinea pig anti-(Doublecortin)DCX (1:400, Millipore Cat# AB2253), mouse anti-ASCL1 (1:100, BD Biosciences Cat# 556604), rabbit anti-KI67 (1:100, Fisher Scientific Cat# RM-9106-S), and chicken anti-GFP (1:400, AvesLab Cat# GFP-1020).

Techniques: Over Expression, Injection

Journal: bioRxiv

Article Title: Purinergic Receptor P2Y 13 Controls Activation and Mode of Division in Subependymal Adult Neural Stem Cells

doi: 10.1101/2024.11.29.626065

Figure Lengend Snippet: Transcriptomic analysis of the RNA-seq data obtained from P2Y 13 overexpressing cells in vivo . A. Scheme of the experimental design: right panel created with BioRender.com. B. A principal component analysis (PCA) of the most variably expressed (top 3,000) genes of the samples profiled, colored by condition: control ( FO_C , blue), P2Y 13 overexpression ( FO_Y , green). C. Heat-map of the top 1,000 most variably expressed genes across the samples profiled. The expression of each gene was scaled as a z-score, and the genes and sample labels were sorted by hierarchical clustering. D. Heat-map of the genes associated with the activation/quiescence equilibrium and self-renewal. The expression of each gene was scaled as a z-score, and the genes and sample labels were sorted by hierarchical clustering. E. Volcano plot showing the differential expression of genes between P2Y 13 overexpressing and control samples (n=3, PY 13 and 3 controls). Differentially expressed genes (DEGs, adjusted p-value <0.05) are in red and green when upregulated or downregulated in the P2Y 13 overexpressing samples, respectively. The bar plot represents the number of DEGs. F. Overrepresentation of gene ontology (GO) terms for biological processes from the DEGs (adjusted p-value <0.05) between the P2Y 13 overexpressing and control samples. A customized selection (18) of significant GO terms with the highest gene ratio (top 100) is displayed for clearer representation. The terms are ordered by significance, representing their adjusted p-value (x-axis), and the expressed genes were used as the background in this analysis. G. Stacked bar plot of the inferred cellular composition of neural progenitors for each condition. The cell deconvolutional analysis was carried out using CIBERSORTx, and the gene signatures of the neural progenitors were retrieved from the data generated in Belenguer et al., 2021.

Article Snippet: Both the cells and tissue sections were then incubated overnight at 4 °C with the primary antibodies: rabbit anti-P2Y 13 (1:100, Alomone Labs Cat# APR-009), rabbit anti-P2Y 1 (1:100, Alomone Labs Cat# APR-017), rabbit anti-SOX2 (1:100, ABclonal Cat# A0561), mouse anti-GFAP (1:200, Sigma-Aldrich Cat# G3893), mouse anti-βIII-Tubulin (1:800, Sigma-Aldrich Cat# T8660), guinea pig anti-(Doublecortin)DCX (1:400, Millipore Cat# AB2253), mouse anti-ASCL1 (1:100, BD Biosciences Cat# 556604), rabbit anti-KI67 (1:100, Fisher Scientific Cat# RM-9106-S), and chicken anti-GFP (1:400, AvesLab Cat# GFP-1020).

Techniques: RNA Sequencing Assay, In Vivo, Control, Over Expression, Expressing, Activation Assay, Selection, Generated

Journal: bioRxiv

Article Title: Purinergic Receptor P2Y 13 Controls Activation and Mode of Division in Subependymal Adult Neural Stem Cells

doi: 10.1101/2024.11.29.626065

Figure Lengend Snippet: Neurogenic trees from the ventral wall of the SEZ tracked in culture following treatment with the P2Y 13 agonist 2MesADP, in the presence or absence of the MRS2211 antagonist. A Representative symmetric neurogenic tree obtained in control conditions after 6 days in culture (N, neuron; X, cell death). B Complex symmetric neurogenic trees of 5 rounds of division obtained in the presence of 2MeSADP after 6 days in culture (N, neuron; X, cell death). The phase contrast images in both A and B depict the lineage progression in the live imaging experiment (day-hour-min). The last images show post-imaging immunocytochemistry of the neuroblast progeny (βIII-tubulin in green) Scale bar 30 µm. C Clones undergoing 1-6 rounds of division in the live imaging experiments (n=5) (n=4 for MRS2211). D Summary of all the clones tracked undergoing 4 or 5 rounds of division in our live imaging experiments, either in control conditions, or when exposed to 2MeSADP or 2MeSADP + MRS2211 (n=5) (n=4 for MRS2211). E Cell survival in the lineage trees (n=5). In all cases the progeny generated were identified by post-imaging immunocytochemistry. All graphs show the mean ±SEM: *p<0.05, and **p<0.01 (ANOVA with a Tukey’s post-test).

Article Snippet: Both the cells and tissue sections were then incubated overnight at 4 °C with the primary antibodies: rabbit anti-P2Y 13 (1:100, Alomone Labs Cat# APR-009), rabbit anti-P2Y 1 (1:100, Alomone Labs Cat# APR-017), rabbit anti-SOX2 (1:100, ABclonal Cat# A0561), mouse anti-GFAP (1:200, Sigma-Aldrich Cat# G3893), mouse anti-βIII-Tubulin (1:800, Sigma-Aldrich Cat# T8660), guinea pig anti-(Doublecortin)DCX (1:400, Millipore Cat# AB2253), mouse anti-ASCL1 (1:100, BD Biosciences Cat# 556604), rabbit anti-KI67 (1:100, Fisher Scientific Cat# RM-9106-S), and chicken anti-GFP (1:400, AvesLab Cat# GFP-1020).

Techniques: Control, Imaging, Immunocytochemistry, Clone Assay, Generated

Journal: bioRxiv

Article Title: Purinergic Receptor P2Y 13 Controls Activation and Mode of Division in Subependymal Adult Neural Stem Cells

doi: 10.1101/2024.11.29.626065

Figure Lengend Snippet: Effect of the P2Y 13 receptor on NSC self-renewal. A . Quantification of the symmetric lineage trees (generating only neuroblasts) and the asymmetric lineage trees (generating neuroblasts and new NSCs through self-renewal events) in control conditions, or on exposure to 2MeSADP or 2MeSADP + MRS2211 (n=4). B. Proportion of GFAP + /SOX2 + NSCs relative to the total number of cells in the culture according to the following labels: “Initial” indicates the proportion of GFAP + /SOX2 + in the culture and the “Quiescent” cells are the fraction of the initial cells that remain quiescent throughout the live imaging experiments. The “Clones” reflect the fraction of the initial cells that undergo lineage progression (Control and 2MeSADP n=5 and 2MeSADP+MRS2211 n = 4). C. The models represent the stereotypic behavior of NSCs under control conditions and when exposed to 2MeSADP or 2MeSADP+MRS211. Note how 2MeSADP increases the speed in the cell cycle while impeding self-renewal divisions. By contrast, MRS2211 instructs NSCs to remain quiescent. D. Cell Cycle length within the complex trees tracked (≥4 rounds of division). E . Cell Cycle length for the first division within the complex trees tracked (≥4 rounds of division, n= 5). Note that this first division is normally associated with slow-dividing astroglia, yet 2MeSADP significantly increase the speed of the cell cycle (n=5). All the graphs show the mean ±SEM: *p<0.05, **p<0.01 (T-test for D, E and ANOVA with a Tukeys post-test for B ).

Article Snippet: Both the cells and tissue sections were then incubated overnight at 4 °C with the primary antibodies: rabbit anti-P2Y 13 (1:100, Alomone Labs Cat# APR-009), rabbit anti-P2Y 1 (1:100, Alomone Labs Cat# APR-017), rabbit anti-SOX2 (1:100, ABclonal Cat# A0561), mouse anti-GFAP (1:200, Sigma-Aldrich Cat# G3893), mouse anti-βIII-Tubulin (1:800, Sigma-Aldrich Cat# T8660), guinea pig anti-(Doublecortin)DCX (1:400, Millipore Cat# AB2253), mouse anti-ASCL1 (1:100, BD Biosciences Cat# 556604), rabbit anti-KI67 (1:100, Fisher Scientific Cat# RM-9106-S), and chicken anti-GFP (1:400, AvesLab Cat# GFP-1020).

Techniques: Control, Imaging, Clone Assay